It’s been 23 years since the U.S. Food and Drug Administration began requiring "nutrition facts" labels on most food products. Is it time to do the same for disclosing the environmental impact of laboratory products?

The world is overrun by debt. How can companies and supply chains protect themselves from the consequences of massive default?

When drug company chief executive Heather Bresch was hauled in front of Congress last year to defend the high price of lifesaving EpiPens, she drew skeptical lawmakers’ attention to a large poster board that blamed the skyrocketing price tag on a coterie of drug supply chain middlemen. Of EpiPen’s $608 list price, her company, Mylan, received only $274, Bresch said.

Worried about managing supply-chain risk? All you need is cash.